Editorial: time to eat? Skipping breakfast in metabolic-associated fatty liver disease-Authors' reply

被引:0
|
作者
Xie, Jiarong [1 ,2 ]
Xu, Lei [1 ,2 ]
Xu, Chengfu [2 ]
机构
[1] Ningbo First Hosp, Dept Gastroenterol, Ningbo, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 1, Dept Gastroenterol, Sch Med, Hangzhou, Peoples R China
关键词
D O I
10.1111/apt.16773
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:494 / 494
页数:1
相关论文
共 50 条
  • [31] Metabolic-associated fatty liver disease and sarcopenia: A double whammy
    Viswanath, Aditya
    Fouda, Sherouk
    Fernandez, Cornelius James
    Pappachan, Joseph M.
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (02) : 152 - 163
  • [32] Roles of gut microbes in metabolic-associated fatty liver disease
    Chen, Chun-Yao
    Ho, Han-Chen
    TZU CHI MEDICAL JOURNAL, 2023, 35 (04): : 279 - 289
  • [33] METABOLIC-ASSOCIATED FATTY LIVER DISEASE AND SARCOPENIA: A SYSTEMATIC REVIEW
    Fouda, S.
    Pappachan, J. M.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2023, 35 : S559 - S560
  • [34] Management of metabolic-associated fatty liver disease: The diabetology perspective
    Jeeyavudeen, Mohammad Sadiq
    Khan, Shahanas K. A.
    Fouda, Sherouk
    Pappachan, Joseph M.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (01) : 126 - 143
  • [35] Management of metabolic-associated fatty liver disease: The diabetology perspective
    Mohammad Sadiq Jeeyavudeen
    Shahanas K A Khan
    Sherouk Fouda
    Joseph M Pappachan
    World Journal of Gastroenterology, 2023, 29 (01) : 126 - 143
  • [36] Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update
    Fouda, Sherouk
    Vennikandam, Madhu Mathew
    Pappachan, Joseph M.
    Fernandez, Cornelius J.
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (05) : 947 - 954
  • [37] Editorial: treating strictures in inflammatory bowel disease-authors' reply
    Rieder, Florian
    Feagan, Brian G.
    Jairath, Vipul
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (11-12) : 1313 - 1314
  • [38] Letter: skipping breakfast is associated with an increased long-term cardiovascular mortality in metabolic dysfunction-associated fatty liver disease (MAFLD) but not in MAFLD-free individuals. Authors' reply
    Xie, Jiarong
    Xu, Lei
    Xu, Chengfu
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (08) : 1067 - 1068
  • [39] Gut microbiome composition and metabolic activity in metabolic-associated fatty liver disease
    Zhang, Daya
    Wang, Qi
    Li, Da
    Chen, Shiju
    Chen, Jinrun
    Zhu, Xuli
    Bai, Feihu
    VIRULENCE, 2025, 16 (01)
  • [40] Sex dimorphism and metabolic profiles in management of metabolic-associated fatty liver disease
    Martin-Grau, Maria
    Monleon, Daniel
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (06) : 1236 - 1244